Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
First patient dosed in Immutep’s TACTI-004 Phase 3 non-small cell lung cancer trial
March 25, 2025 - - Latest News -
Chimeric announces US patent allowed for CHM CDH17 technology
March 25, 2025 - - Latest News -
Nanotechnology could improve odds in treating aggressive breast cancers
March 25, 2025 - - Latest News -
Noxopharm expands collaboration with Hudson Institute
March 25, 2025 - - Latest News -
Opthea now managing the fallout of clinical trial result
March 25, 2025 - - Latest News -
Immutep confirms presentation of pivotal TACTI-004 trial at major international meeting
March 20, 2025 - - Latest News -
Osteopore enhances strategic refocus with early cessation of dental grant project
March 20, 2025 - - Latest News